• OPEN AN ACCOUNT
Indian Indices
Nifty
25,062.10 -157.80
(-0.63%)
Sensex
82,184.17 -542.47
( -0.66%)
Bank Nifty
57,066.05 -144.40
( -0.25%)
Nifty IT
36,135.80 -815.70
( -2.21%)
Global Indices
Nasdaq
44,713.34 -317.96
(-0.71%)
Dow Jones
6,384.16 4.25
(0.07%)
Hang Seng
41,918.59 747.27
(1.82%)
Nikkei 225
9,138.37 76.88
(0.85%)
Forex
USD-INR
86.32 0.09
(0.10%)
EUR-INR
101.10 0.55
(0.54%)
GBP-INR
116.50 0.44
(0.38%)
JPY-INR
0.59 0.00
(0.54%)

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506197
INE416D01022
100.3479373
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BLISSGVS
23.34
1613.06
EPS(TTM)
Face Value()
Div & Yield %
6.55
1
0.33
 

Jainco Projects (India) standalone net profit declines 33.33% in the March 2025 quarter
May 31,2025
Net profit of Jainco Projects (India) declined 33.33% to Rs 0.04 crore in the quarter ended March 2025 as against Rs 0.06 crore during the previous quarter ended March 2024. Sales rose 285.71% to Rs 0.54 crore in the quarter ended March 2025 as against Rs 0.14 crore during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 0.01 crore in the year ended March 2025. There were no net profit/loss reported during the previous year ended March 2024. Sales rose 231.82% to Rs 0.73 crore in the year ended March 2025 as against Rs 0.22 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales0.540.14 286 0.730.22 232
OPM %88.8971.43 -75.3422.73 -
PBDT0.040.10 -60 0.020.05 -60
PBT0.040.06 -33 0.010 0
NP0.040.06 -33 0.010 0